Additive Anti-inflammatory Action for Aortopathy & Arteriopathy

Enrolling by invitationOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2040

Study Completion Date

December 31, 2040

Conditions
Acute Aortic Syndrome
Interventions
OTHER

observation

Data were collected by a designed form. Statistic software was used to analyze clinical data.

Trial Locations (29)

210029

The First Affiliated Hospital of Nanjing Medical University, Nanjing

225001

Subei People's Hospital of Jiangsu Province, Yangzhou

250012

Qilu Hospital of Shandong University, Jinan

300088

the Second Affiliated Hospital of Nanchang University, Nanchang

Unknown

Beijing Fuwai Hospital Chinese Academy of Medical Sciences, Beijing

Chongqing Hospital of Jiangsu Provincial People's Hospital, Chongqing

Guangdong Provincial People's Hospital, Guangzhou

The First Affiliated Hospital of Guangxi Medical University, Nanning

The Second Affiliated Hospital of Harbin Medical University, Harbin

Suqian Hospital of of Nanjing Medical University, Suqian

Shanghai DeltaHealth Hospital, Shanghai

Shanxi Cardiovascular Hospital, Taiyuan

West China Hospital of Sichuan University, Chengdu

The Friendship Hospital of Yili Kazak Autonomous Prefecture, Kazak

The Seventh Affiliated Hospital of Xinjiang Medical University, Ürümqi

The First Affiliated Hospital of Kunming Medical University, Kunming

Beijing Anzhen Hospital Capital Medical University, Beijing

Beijing Chaoyang Hospital, Beijing

the First Affiliated Hospital of Bengbu Medical College, Bengbu

Xiangya Hospital Central South University, Changsha

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

the First Affiliated Hospital of Guilin Medical College, Guilin

Nanjing First Hospital, Nanjing Medical University, Nanjing

the Affiliated Hospital of Qingdao University, Qingdao

Shanghai East Hospital Tongji University, Shanghai

the First Affiliated Hospital of Shantou University Medical College, Shantou

Teda International Cardiovascular Hospital, Tianjin

Tianjin Chest Hospital, Tianjin

Xiamen Cardiovascular Hospital, Xiamen

Sponsors
All Listed Sponsors
collaborator

Beijing Anzhen Hospital

OTHER

lead

Nanjing Medical University

OTHER

NCT04398992 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy | Biotech Hunter | Biotech Hunter